These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Design of P1' and P3' residues of trivalent thrombin inhibitors and their crystal structures. Slon-Usakiewicz JJ, Sivaraman J, Li Y, Cygler M, Konishi Y. Biochemistry; 2000 Mar 07; 39(9):2384-91. PubMed ID: 10694407 [Abstract] [Full Text] [Related]
25. Role of the amino- and carboxyl-terminal domains of thrombin receptor-derived polypeptides in biological activity in vascular endothelium and gastric smooth muscle: evidence for receptor subtypes. Hollenberg MD, Laniyonu AA, Saifeddine M, Moore GJ. Mol Pharmacol; 1993 Jun 07; 43(6):921-30. PubMed ID: 8391118 [Abstract] [Full Text] [Related]
28. Probing thrombin's ability to accommodate a V34F substitution within the factor XIII activation peptide segment (28-41). Isetti G, Maurer MC. J Pept Res; 2004 Mar 07; 63(3):241-52. PubMed ID: 15049836 [Abstract] [Full Text] [Related]
29. The action of thrombin on peptide p-nitroanilide substrates. Substrate selectivity and examination of hydrolysis under different reaction conditions. Lottenberg R, Hall JA, Blinder M, Binder EP, Jackson CM. Biochim Biophys Acta; 1983 Feb 15; 742(3):539-57. PubMed ID: 6838888 [Abstract] [Full Text] [Related]
30. BJ-48, a novel thrombin-like enzyme from the Bothrops jararacussu venom with high selectivity for Arg over Lys in P1: Role of N-glycosylation in thermostability and active site accessibility. Silva-Junior FP, Guedes HL, Garvey LC, Aguiar AS, Bourguignon SC, Di Cera E, Giovanni-De-Simone S. Toxicon; 2007 Jul 15; 50(1):18-31. PubMed ID: 17433397 [Abstract] [Full Text] [Related]
32. Structure-based understanding of ligand affinity using human thrombin as a model system. Nienaber VL, Mersinger LJ, Kettner CA. Biochemistry; 1996 Jul 30; 35(30):9690-9. PubMed ID: 8703940 [Abstract] [Full Text] [Related]
33. Substrates with charged P1 residues are efficiently hydrolyzed by serine carboxypeptidases when S3-P1 interactions are facilitated. Olesen K, Breddam K. Biochemistry; 1997 Oct 07; 36(40):12235-41. PubMed ID: 9315861 [Abstract] [Full Text] [Related]
34. Thrombin activity is unaltered by N-terminal truncation of factor XIII activation peptides. Isetti G, Maurer MC. Biochemistry; 2004 Apr 13; 43(14):4150-9. PubMed ID: 15065858 [Abstract] [Full Text] [Related]
35. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies. Wang H, Vath GM, Gleason KJ, Hanna PE, Wagner CR. Biochemistry; 2004 Jun 29; 43(25):8234-46. PubMed ID: 15209520 [Abstract] [Full Text] [Related]
36. [Inhibitory effect of methyl esters of arginine-containing oligopeptides on thrombin and trypsin]. Poiarkova SA, Kibirev VK, Serebrianyĭ SB. Ukr Biokhim Zh (1978); 1987 Jun 29; 59(5):5-11. PubMed ID: 3686693 [Abstract] [Full Text] [Related]
38. Conformational analysis of gamma' peptide (410-427) interactions with thrombin anion binding exosite II. Sabo TM, Farrell DH, Maurer MC. Biochemistry; 2006 Jun 20; 45(24):7434-45. PubMed ID: 16768439 [Abstract] [Full Text] [Related]
39. [Effect of temperature on the hydrolysis of some synthetic substrates by thrombin and trypsin]. Kibirev VK. Biokhimiia; 1981 Oct 20; 46(10):1799-806. PubMed ID: 7306600 [Abstract] [Full Text] [Related]
40. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1. Rezaie AR. Biochemistry; 1998 Sep 22; 37(38):13138-42. PubMed ID: 9748320 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]